Featured Research

from universities, journals, and other organizations

Key Peptides Found That Stop -- Even Reverse -- Kidney Disease In Lupus

Date:
May 6, 1999
Source:
Northwestern University
Summary:
Northwestern University Medical School researchers have identified key peptides -- small bits of proteins -- that halt kidney disease in lupus, an autoimmune disease that attacks the body's own DNA.

CHICAGO --- Northwestern University Medical School researchers have identified key peptides -- small bits of proteins -- that halt kidney disease in lupus, an autoimmune disease that attacks the body's own DNA.

In an article in the May 15 issue of the Journal of Immunology, Syamal Datta, M.D., the Solovy Arthritis Research Society Professor, and colleagues at Northwestern reported that brief therapy with the peptides in young, lupus-prone mice markedly delayed the onset of severe, lupus-related kidney disease. Long-term therapy with the peptides in adult mice with established kidney disease prolonged survival and even stopped progression of their disease.

Remarkably, one of the peptides, called H4 16-39, not only arrested but reversed kidney disease in the mice and allowed them to live almost a normal lifespan.

Datta's group used a special method of administering the peptides in a soluble, high-dose form -- a technique called tolerization -- to induce tolerance or inactivate disease-causing T helper cells and B cells. T helper and B cells are the mediators of the body's immune response.

Interestingly, the most effective peptide, H4 16-39, inhibited function of lupus nephritis-causing T helper and B cells because it contains molecules (epitopes) on its surface that are "recognized" by both cell types.

The normal immune system produces antibodies and T helper cells in response to invading antigens, e.g., toxins, foreign proteins or whole organisms, such as bacteria or viruses. Portions of the foreign protein molecules are recognized by the antibody receptor and the T helper cell receptor molecules on infection-fighting T and B cells. In response, B cells -- with the help of the T cells -- produce antibodies to wipe out the invaders.

Datta had earlier discovered that in lupus, specific T helper cells react to nucleosomes, a complex of DNA and histone proteins that forms a cell's nuclear material. Nucleosomes are a natural byproduct of cell death and are normally cleared by the system without causing immune response. But in lupus, the immune system "sees" nucleosomes as an antigen, causing T helper cells to drive B cells to produce antibodies against the body's own genetic material.

Datta also found that the disease-causing T helper cells and B cells of lupus have a regulatory defect in the expression of a molecule called CD40 ligand, which results in abnormal costimulatory signals that sustain production of autoantibodies. This discovery has led to another type of therapy for lupus using anti-CD40 ligand antibody.

The Northwestern investigators currently are conducting research to find peptides similar to those used in the mouse models for treating human lupus.

Datta is a professor of medicine and of microbiology-immunology at the Medical School and director of the biomedical research component of the Northwestern Multipurpose Arthritis Center. His co-investigators on this study were Arunan Kaliyaperumal, assistant research professor, and Marissa A. Michaels, also of Northwestern.


Story Source:

The above story is based on materials provided by Northwestern University. Note: Materials may be edited for content and length.


Cite This Page:

Northwestern University. "Key Peptides Found That Stop -- Even Reverse -- Kidney Disease In Lupus." ScienceDaily. ScienceDaily, 6 May 1999. <www.sciencedaily.com/releases/1999/05/990506070237.htm>.
Northwestern University. (1999, May 6). Key Peptides Found That Stop -- Even Reverse -- Kidney Disease In Lupus. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/1999/05/990506070237.htm
Northwestern University. "Key Peptides Found That Stop -- Even Reverse -- Kidney Disease In Lupus." ScienceDaily. www.sciencedaily.com/releases/1999/05/990506070237.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins